Cite
Zhang X, Li B, Yu J, et al. Correction to: MYC-dependent downregulation of telomerase by FLT3 inhibitors is required for their therapeutic efficacy on acute myeloid leukemia. Ann Hematol. 2018;97(7):1299doi: 10.1007/s00277-018-3340-7.
Zhang, X., Li, B., Yu, J., Dahlström, J., Tran, A. N., Björkholm, M., & Xu, D. (2018). Correction to: MYC-dependent downregulation of telomerase by FLT3 inhibitors is required for their therapeutic efficacy on acute myeloid leukemia. Annals of hematology, 97(7), 1299. https://doi.org/10.1007/s00277-018-3340-7
Zhang, Xiaolu, et al. "Correction to: MYC-dependent downregulation of telomerase by FLT3 inhibitors is required for their therapeutic efficacy on acute myeloid leukemia." Annals of hematology vol. 97,7 (2018): 1299. doi: https://doi.org/10.1007/s00277-018-3340-7
Zhang X, Li B, Yu J, Dahlström J, Tran AN, Björkholm M, Xu D. Correction to: MYC-dependent downregulation of telomerase by FLT3 inhibitors is required for their therapeutic efficacy on acute myeloid leukemia. Ann Hematol. 2018 Jul;97(7):1299. doi: 10.1007/s00277-018-3340-7. PMID: 29744585; PMCID: PMC6828086.
Copy
Download .nbib